{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:08:07Z","timestamp":1761059287417},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,2,16]],"date-time":"2012-02-16T00:00:00Z","timestamp":1329350400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s11886-012-0249-y","type":"journal-article","created":{"date-parts":[[2012,2,15]],"date-time":"2012-02-15T07:07:58Z","timestamp":1329289678000},"page":"200-207","source":"Crossref","is-referenced-by-count":3,"title":["The Potential Utility of 123I-mIBG in Atrial Fibrillation and in the Electrophysiology Laboratory"],"prefix":"10.1007","volume":"14","author":[{"given":"Marc","family":"Ovadia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin S.","family":"Duque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,2,16]]},"reference":[{"key":"249_CR1","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/hc0902.104712","volume":"105","author":"H Oral","year":"2002","unstructured":"Oral H, Knight BP, Tada H, et al. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation. 2002;105:1077\u201381.","journal-title":"Circulation"},{"key":"249_CR2","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/eurheartj\/ehi583","volume":"27","author":"G Stabile","year":"2006","unstructured":"Stabile G, Bertaglia E, Senatore G, et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation. A Prospective, multi-centre, randomized, controlled study (Catheter ablation for the cure of atrial fibrillation study). Eur Heart J. 2006;27:216\u201321.","journal-title":"Eur Heart J"},{"key":"249_CR3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/jama.2009.2029","volume":"303","author":"DJ Wilber","year":"2010","unstructured":"Wilber DJ, Pappone C, Neuzil P, et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation. A Randomized controlled trial. JAMA. 2010;303:333\u201340.","journal-title":"JAMA"},{"key":"249_CR4","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1001\/jama.293.21.2634","volume":"293","author":"OM Wazni","year":"2005","unstructured":"Wazni OM, Marrouche NF, Martin DO, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation. A Randomized trial. JAMA. 2005;293:2634\u201340.","journal-title":"JAMA"},{"key":"249_CR5","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/01.CIR.0000157153.30978.67","volume":"111","author":"R Cappato","year":"2005","unstructured":"Cappato R, Calkins H, Chen S-A, et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation. 2005;111:1100\u20135.","journal-title":"Circulation"},{"key":"249_CR6","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.jacc.2009.02.022","volume":"53","author":"R Cappato","year":"2009","unstructured":"\u2022 Cappato R, Calkins H, Chen S-A, et al. Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation. J Am Coll Cardiol. 2009;53:1798\u2013803. This is a review of the most adverse outcome in 45,000 procedures.","journal-title":"J Am Coll Cardiol"},{"key":"249_CR7","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jacc.2005.10.046","volume":"47","author":"R Ponti De","year":"2006","unstructured":"De Ponti R, Cappato R, Curnis A, et al. Trans-septal catheterization in the electrophysiology laboratory. Data from a multicenter survey spanning 12\u00a0years. J Am Coll Cardiol. 2006;47:1037\u201342.","journal-title":"J Am Coll Cardiol"},{"key":"249_CR8","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nrcardio.2009.136","volume":"6","author":"A Chugh","year":"2009","unstructured":"\u2022\u2022 Chugh A, Oral H. Preventing serious complications during AF ablation. Nat Rev Cardiol. 2009;6:562\u20133. A clinician-scientist with remarkable foresight reflects on the needed evolution of a procedure he was instrumental in introducing.","journal-title":"Nat Rev Cardiol"},{"key":"249_CR9","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/01.CIR.0000140263.20897.42","volume":"110","author":"DM Lloyd-Jones","year":"2004","unstructured":"Lloyd-Jones DM, Wang TJ, et al. Lifetime risk for development of atrial fibrillation: the Framingham heart study. Circulation. 2004;110:1042\u20136.","journal-title":"Circulation"},{"key":"249_CR10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1067\/mhj.2000.107547","volume":"140","author":"SM Al-Khatib","year":"2000","unstructured":"Al-Khatib SM, Wilkinson WE, Sanders LL, et al. Observations on the transition from intermittent to permanent atrial fibrillation. Am Heart J. 2000;140:142\u20135.","journal-title":"Am Heart J"},{"key":"249_CR11","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1253\/circj.68.568","volume":"68","author":"T Kato","year":"2004","unstructured":"Kato T, Yamashita T, Sagara K, et al. Progressive nature of paroxysmal atrial fibrillation. Observations from a 14-year follow-up study. Circ J. 2004;68:568\u201372.","journal-title":"Circ J"},{"key":"249_CR12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jcmg.2009.09.015","volume":"3","author":"DM Raffel","year":"2010","unstructured":"Raffel DM, Wieland DM. Development of mIBG as a cardiac innervation imaging agent. JACC Cardiovasc Imag. 2010;3:111\u20136.","journal-title":"JACC Cardiovasc Imag"},{"key":"249_CR13","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1021\/jm00317a017","volume":"10","author":"JH Short","year":"1967","unstructured":"Short JH, Darby TJ. Sympathetic nervous system blocking agents. III. Derivatives of benzylguanidine. J Med Chem. 1967;10:833\u201340.","journal-title":"J Med Chem"},{"key":"249_CR14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1021\/jm00368a008","volume":"27","author":"DM Wieland","year":"1984","unstructured":"Wieland DM, Mangner TJ, Inbasekaran MN, et al. Adrenal medulla imaging agents: a structure-distribution relationship study of radiolabeled aralkylguanidines. J Med Chem. 1984;27:149\u201355.","journal-title":"J Med Chem"},{"key":"249_CR15","first-page":"1620","volume":"28","author":"JC Sisson","year":"1987","unstructured":"Sisson JC, Wieland DM, Sherman P, et al. Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. J Nucl Med. 1987;28:1620\u20134.","journal-title":"J Nucl Med"},{"key":"249_CR16","first-page":"1625","volume":"28","author":"JC Sisson","year":"1987","unstructured":"Sisson JC, Shapiro B, Meyers L, et al. Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med. 1987;28:1625\u201336.","journal-title":"J Nucl Med"},{"key":"249_CR17","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.jacc.2010.01.014","volume":"55","author":"AF Jacobson","year":"2010","unstructured":"Jacobson AF, Senior F, Cerqueira MD, et al. Myocardial iodine-123 Metaiodobenzylguanidine imaging and cardiac events in heart failure: results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol. 2010;55:2212\u201321.","journal-title":"J Am Coll Cardiol"},{"key":"249_CR18","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jcmg.2010.10.005","volume":"4","author":"Y Akutsu","year":"2011","unstructured":"\u2022\u2022 Akutsu Y, Kaneko K, Kodama Y, et al. Iodine-123 Imaging for predicting the development of atrial fibrillation. JACC Cardiovasc Imag. 2011;4:78\u201386. This paper is the seminal work in the field.","journal-title":"JACC Cardiovasc Imag"},{"key":"249_CR19","first-page":"1089","volume":"46","author":"M Mabuchi","year":"2005","unstructured":"Mabuchi M, Imamura M, Kubo N, et al. Sympathetic denervation and reinnervation after the MAZE procedure. J Nucl Med. 2005;46:1089\u201394.","journal-title":"J Nucl Med"},{"key":"249_CR20","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/CIRCULATIONAHA.108.825380","volume":"119","author":"EJ Benjamin","year":"2009","unstructured":"Benjamin EJ, Chen P-S, Bild DE, et al. Prevention of atrial fibrillation: Report from a National Heart, Lung and Blood Institute workshop. Circulation. 2009;119:606\u201318.","journal-title":"Circulation"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-012-0249-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-012-0249-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-012-0249-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:56:18Z","timestamp":1559433378000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-012-0249-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,16]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["249"],"URL":"https:\/\/doi.org\/10.1007\/s11886-012-0249-y","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,16]]}}}